Hydralazine 100mg Injection Vials from Japan
Sterile injectable vials containing 100mg hydralazine for IV use in severe hypertension crises. Meets HTS 3004.90.92.20 as unmixed cardiovascular product in measured doses, suitable for hospital retail dispensing.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.6215%Pharmaceuticals: patented pharma from JP/EU/KR/CH/LI — 15% floor rate
9903.05.860%Universal product exemption (U.S. note 52(b))
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Provide USP <71> sterility and <85> bacterial endotoxin certificates
• Maintain cold chain (2-8°C) with validated shipping; declare as pharmaceutical